Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Schneider, Christian KIssue Date
2013-03
Metadata
Show full item recordCitation
Biosimilars in rheumatology: the wind of change. 2013, 72 (3):315-8 Ann. Rheum. Dis.Journal
Annals of the rheumatic diseasesPubMed ID
23390018Type
ArticleLanguage
enISSN
1468-2060ae974a485f413a2113503eed53cd6c53
10.1136/annrheumdis-2012-202941
Scopus Count
The following license files are associated with this item:
Related articles
- [Biosimilars antibodies: positioning compared to originators - the experience in rheumatology and the biosimilars of trastuzumab in oncology].
- Authors: Pivot X, Goupille P
- Issue date: 2019 Dec
- Biosimilars in rheumatology: perspective and concerns.
- Authors: Scheinberg MA, Azevedo VF
- Issue date: 2014 Mar
- European perspective on biosimilars.
- Authors: Wadhwa M, Thorpe R
- Issue date: 2013 Mar
- Competition in the Age of Biosimilars.
- Authors: Chandra A, Vanderpuye-Orgle J
- Issue date: 2015 Jul 21
- Biosimilars: State of Clinical and Regulatory Science.
- Authors: Klein AV, Wang J, Feagan BG, Omoto M
- Issue date: 2017


